Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.

@article{Dimar2006ClinicalOA,
  title={Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.},
  author={John R. Dimar and Steven Glassman and Kenneth J Burkus and Leah Yacat Carreon},
  journal={Spine},
  year={2006},
  volume={31 22},
  pages={2534-9; discussion 2540}
}
STUDY DESIGN This is a prospective, randomized study comparing iliac crest bone graft to bone morphogenetic protein (BMP)/compression resistant matrix in instrumented posterolateral fusions for single-level lumbar degenerative disease. A higher recombinant human bone morphogenetic protein (rhBMP)-2 dose and a carrier specific for posterior spine applications were used. OBJECTIVES As part of a Food and Drug Administration IDE study, clinical outcomes and fusion rates of single-level… CONTINUE READING
92 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 92 extracted citations

Similar Papers

Loading similar papers…